American Diabetes Association - Professional Publications

American Diabetes Association - Professional Publications The monthly, peer-reviewed journal focuses primarily on the physiology and pathophysiology of diabetes and its complications.

The Professional Publications of the American Diabetes Association - Diabetes, Diabetes Care, Clinical Diabetes, Diabetes Spectrum, & books - are the premier scientific & medical publications devoted to diabetes research, care, prevention, and treatment. With impact factors of 9.332 and 17.152, Diabetes and Diabetes Care are the premier journals devoted exclusively to original diabetes-related research:

Diabetes, ADA's flagship research publication, is the highest-ranked journal devoted to basic diabetes research. Diabetes Care, also a monthly peer-reviewed research publication, is the highest ranked journal devoted exclusively to diabetes treatment, care, and prevention. ADA treatment guidelines, position statements, and clinical practice recommendations are published in Diabetes Care. Clinical Diabetes and Diabetes Spectrum are ADA’s two cutting-edge “translational” journals:

Clinical Diabetes is a quarterly journal for primary care physicians, general practitioner, and other health care professionals. Each issue contains one or more feature articles that focus on the latest trends and innovations in diabetes care and treatment, as well as mini-reviews of landmark studies, practical treatment pointers, and best practices related to diabetes care. Clinical Diabetes focuses on translating recent diabetes-related research into clinical applications. Diabetes Spectrum is a quarterly journal for diabetes educators, nutritionists, nurse practitioners, and other health care providers. The journal’s “From Research to Practice” section provides in-depth explorations of selected diabetes care topics, with a primary focus on translating current research findings into educational and treatment strategies. ADA’s Standards of Medical Care in Diabetes are the most essential and up-to-date resource for clinicians, dietitians, and educators on the treatment of diabetes. Published each year with the January issue of Diabetes Care, the CPRs include ADA's standards for diagnosing and treating diabetes, nutrition recommendations and principles, and position statements on managing diabetes and its complications in various settings.

01/30/2026

🚨 NEW special

In the second episode of a special Diabetes Core Update series with , shares perspectives on living with obesity & describes how bias presents in clinical settings.

👂 Listen now at: https://diabetesjournals.org/journals/pages/podcasts_weight_bias

This special edition of Diabetes Core Update is sponsored by
Eli Lilly and Company

American Diabetes Association – DiabetesPro American Diabetes Association

01/29/2026

🚨 NEW special

In this Special Edition: What’s Next – An Update on Beta Cell Function, Neil Skolnik, featuring Dr. Melena Bellin, covers the latest updates on beta cell function and its role in the early detection of .

👂 Listen now at: bit.ly/3M9TpnM.

01/28/2026

Medicaid obesity treatment could return $3.81 per dollar invested, generating $20.4B social value at a cost of $5.4B over 5 years via improved health outcomes. Coverage = investment, not expense.

Free to read in Diabetes, Obesity, and Cardiometabolic CARE ➡️ doi.org/10.2337/doci25-0005

American Diabetes Association
American Diabetes Association – DiabetesPro

OBJECTIVE. To assess clinical, economic, and social impacts of treating obesity among adult Medicaid beneficiaries, including budget implications and value

01/28/2026

🚨 For February, we've got a brand new ep of , the that covers the most important articles in the field of .

🎧Listen at: https://bit.ly/DOC_Update

Topics this month include:
✨Semaglutide & kidney outcomes in T2D
✨The SODAS Trial
✨and more!

FEATURED ARTICLES:
✨ The Effect of Substituting Water for Artificially Sweetened Beverages on Glycemic and Weight Measures in People With Type 2 Diabetes: The Study of Drinks With Artificial Sweeteners (SODAS), a Randomized Trial doi.org/10.2337/dc25-1516
✨ Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial doi.org/10.2337/dc25-1080

Hosted by Drs. Neil Skolnik & John Russell

American Diabetes Association – DiabetesPro American Diabetes Association

Nonelderly adults with diabetes faced greater financial hardship (40% vs 28%) than those without, with 13% reported mult...
01/27/2026

Nonelderly adults with diabetes faced greater financial hardship (40% vs 28%) than those without, with 13% reported multiple forms of hardship, across income and insurance groups.

Free to read ➡️ doi.org/10.2337/doc25-0037

American Diabetes Association
American Diabetes Association – DiabetesPro

Honoring the Legacy of Clinical Diabetes and Diabetes SpectrumFor more than 40 years, Clinical Diabetes® and Diabetes Sp...
01/23/2026

Honoring the Legacy of Clinical Diabetes and Diabetes Spectrum

For more than 40 years, Clinical Diabetes® and Diabetes Spectrum® have been at the forefront of advancing the American Diabetes Association® (ADA) mission, providing practical, evidence-based guidance that has shaped diabetes care worldwide. Their final issues celebrate the insights, voices, and ideas that have informed and supported millions of healthcare professionals and patients alike.

Check out our featured editorials:
1️⃣ Goodbye and Be Well – doi.org/10.2337/cd25-0071
2️⃣ In Appreciation of Our Journal and Its Extended Family – doi.org/10.2337/cd25-dk05
3️⃣ Looking Back With Gratitude, Looking Forward With Excitement – doi.org/10.2337/ds25-ed05
4️⃣ In Appreciation of Our Journal Family and the Diabetes Interprofessional Care Team – doi.org/10.2337/ds25-dk05

📈 Stay tuned for more from ADA Publications, and let us know which editorial resonates with you most!

American Diabetes Association American Diabetes Association – DiabetesPro

⭐ 📖 Paper of the Month: Feb.B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 DiabetesWilson et al.➡️ https:...
01/21/2026

⭐ 📖 Paper of the Month: Feb.
B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes
Wilson et al.
➡️ https://doi.org/10.2337/db25-0241

Articles are chosen 🗓️ monthly & 🆓 to read online

👀 The Feb 2026 issue of Diabetes Care is here, with the latest research on   management.🔗http://diabetesjournals.org/car...
01/20/2026

👀 The Feb 2026 issue of Diabetes Care is here, with the latest research on management.

🔗http://diabetesjournals.org/care/issue/49/2

Featuring:
✨ Study of Drinks w Artificial Sweeteners (SODAS)
✨ Oral Semaglutide & Kidney Outcomes
✨ & more!

FEATURED ARTICLES
✨ The Effect of Substituting Water for Artificially Sweetened Beverages on Glycemic and Weight Measures in People With Type 2 Diabetes: The Study of Drinks With Artificial Sweeteners (SODAS), a Randomized Trial doi.org/10.2337/dc25-1516
✨Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial doi.org/10.2337/dc25-1080
✨Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention doi.org/10.2337/dc25-2006
✨ Hypoglycemia Beliefs, Impaired Hypoglycemia Awareness, and Severe Hypoglycemia in Insulin-Treated Type 2 Diabetes: Insights From CGM Users doi.org/10.2337/dc25-1778

📸 On the cover: Chronicles of Four Unsung Heroes of Diabetes Research, illustration, 2025, Eleonora Nigro.

American Diabetes Association – DiabetesPro American Diabetes Association

🚨The February 2026 issue of Diabetes has arrived!🔗http://diabetesjournals.org/diabetes/issue/75/2Explore the latest rese...
01/20/2026

🚨The February 2026 issue of Diabetes has arrived!

🔗http://diabetesjournals.org/diabetes/issue/75/2

Explore the latest research on , including:
✨T2D Genetic Risk & T1D Heterogeneity
✨Semaglutide Treatment & Feeding Behaviors
✨& more!

FEATURED ARTICLES:
✨ Prolonged Semaglutide Treatment Reveals Stage-Dependent Changes to Feeding Behavior and Metabolic Adaptations in Male Mice doi.org/10.2337/db25-0678
✨B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes doi.org/10.2337/db25-0241
✨ Urinary Branched-Chain Amino Acid Excretion and Chronic Kidney Disease Progression in Patients With Type 2 Diabetes doi.org/10.2337/db25-0782
✨Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression doi.org/10.2337/db25-0711

📸 On the cover: Hidden in the shadows, B lymphocytes contribute to T1D by eliminating the regulatory T cells that would otherwise protect the islet beta cells. Image courtesy of C.S. Wilson. The original image was created by hand with watercolor, scanned and edited in GIMP, and smoothed and pixel enhanced by GPT5.

American Diabetes Association – DiabetesPro American Diabetes Association

01/15/2026

🚨 NEW special

In part 2 of this special three-part series of Diabetes Core Update,
Neil Skolnik explores automated insulin delivery for patients with type 2, and the practical aspects of prescribing what can be an intimidating technology.

👂 Listen now at: http://diabetesjournals.org/journals/pages/podcasts_aid_t2d

This special edition of Diabetes Core Update is sponsored by Insulet.

American Diabetes Association – DiabetesPro American Diabetes Association

🚨 The final issue of Diabetes Spectrum is live!This bonus fifth issue of the journal’s 38th and final volume offers 120 ...
01/15/2026

🚨 The final issue of Diabetes Spectrum is live!

This bonus fifth issue of the journal’s 38th and final volume offers 120 pages of insights on anxiety & T1D, glucose extremes & neurological impacts, and more!

📖Read now ➡️ diabetesjournals.org/spectrum/issue/38/5

Stay ahead in care!

FEATURED ARTICLES:
✨ Glucose Extremes and Cognitive Function: A Review of the Neurological Impacts of Hypoglycemia and Hyperglycemia in Type 1 Diabetes doi.org/10.2337/ds25-0012
✨ Population Screening for Type 1 Diabetes in Pediatrics via Well-Child Visits: Barriers and Facilitators to Implementation doi.org/10.2337/ds25-0036
✨Exploring the Role of Time in Diabetes Self-Management: A Scoping Review of Challenges, Intervention Strategies, and Implications for Clinical Care doi.org/10.2337/ds25-0050
✨ Anxiety in Youth and Adults With Type 1 Diabetes and Associations With Clinical Outcomes: Data From the T1D Exchange Quality Improvement Collaborative doi.org/10.2337/ds25-0021

📸 On the cover: A happy family sits around a breakfast table with a large plate of sliced cantaloupe. monkeybusinessimages/iStock

American Diabetes Association – DiabetesPro American Diabetes Association

The Study of Drinks With Artificial Sweeteners (SODAS): A randomized trial including people with Type 2 Diabetes who con...
01/14/2026

The Study of Drinks With Artificial Sweeteners (SODAS): A randomized trial including people with Type 2 Diabetes who consumed 🥤 artificially sweetened beverages found no evidence that substituting 🫗 water would improve glycemic-related clinical measures over 24 weeks.

Read here ➡️ doi.org/10.2337/dc25-1516

American Diabetes Association American Diabetes Association – DiabetesPro

Address

2451 Crystal Drive, Suite 900
Arlington, VA
22202

Telephone

+17035491500

Website

https://diabetesjournals.org/journals/pages/podcasts, https://diabetesjournals.org/journa

Alerts

Be the first to know and let us send you an email when American Diabetes Association - Professional Publications posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to American Diabetes Association - Professional Publications:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

With impact factors of 16.02 and 7.72, Diabetes Care and Diabetes are the premier journals devoted exclusively to original diabetes-related research: Diabetes, ADA's flagship research publication, is the highest-ranked journal devoted to basic diabetes research. The monthly, peer-reviewed journal focuses primarily on the physiology and pathophysiology of diabetes and its complications. Diabetes Care, also a monthly peer-reviewed research publication, is the highest ranked journal devoted exclusively to diabetes treatment, care, and prevention. ADA treatment guidelines, position statements, and clinical practice recommendations are published in Diabetes Care. Clinical Diabetes and Diabetes Spectrum are ADA’s two cutting-edge “translational” journals: Clinical Diabetes is a journal for primary care physicians, general practitioner, and other health care professionals. Each issue contains one or more feature articles that focus on the latest trends and innovations in diabetes care and treatment, as well as mini-reviews of landmark studies, practical treatment pointers, and best practices related to diabetes care. The journal publishes 5 times per year. Clinical Diabetes focuses on translating recent diabetes-related research into clinical applications. Diabetes Spectrum is a quarterly journal for diabetes educators, nutritionists, nurse practitioners, and other health care providers. The journal’s “From Research to Practice” section provides in-depth explorations of selected diabetes care topics, with a primary focus on translating current research findings into educational and treatment strategies. ADA’s Standards of Medical Care in Diabetes (formerly the Clinical Practice Recommendations) are the most essential and up-to-date resource for clinicians, dietitians, and educators on the treatment of diabetes. Published each year with the January issue of Diabetes Care, the supplement details ADA's standards for diagnosing and treating diabetes, nutrition recommendations and principles, and position statements on managing diabetes and its complications in various settings.